BACKGROUND: SOTERIA (NCT04796337) is an ongoing open-label study evaluating long-term safety, tolerability, and efficacy of sotatercept in participants with pulmonary arterial hypertension (PAH). METHODS: Eligible adults with PAH on stable background therapy who completed a prior sotatercept study without early discontinuation were enrolled. Participants received subcutaneous sotatercept (
- Preston, I. R.
- Badesch, D.
- Ghofrani, H. A.
- Gibbs, J. S. R.
- Gomberg-Maitland, M.
- Hoeper, M. M.
- Humbert, M.
- McLaughlin, V. V.
- Waxman, A. B.
- Manimaran, S.
- Mikhailova, E.
- Reddy, M.
- Lau, A.
- de Oliveira Pena, J.
- Souza, R.
